1,7-phenanthroline has been researched along with Sarcoma 180 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azevedo, FVPV; Correia, LIV; da Silva, CV; da Silva, MS; do Couto Almeida, J; Goulart, LRF; Guerra, W; Lima, PMAP; Morelli, S; Oliveira Júnior, RJ; Polloni, L; Rodrigues Ávila, VM; Seni Silva, AC; Teixeira, SC; Zóia, MAP | 1 |
| Hakala, MT; Suolinna, EM | 1 |
2 other study(ies) available for 1,7-phenanthroline and Sarcoma 180
| Article | Year |
|---|---|
Action of copper(II) complex with β-diketone and 1,10-phenanthroline (CBP-01) on sarcoma cells and biological effects under cell death.
Topics: Animals; Cell Death; Cell Line, Tumor; Cell Survival; Chelating Agents; Copper; Dose-Response Relationship, Drug; Mice; Phenanthrolines; Sarcoma 180 | 2019 |
Specific protection of folate reductase against chemical and proteolytic inactivation.
Topics: Animals; Carboxypeptidases; Chloromercuribenzoates; Chymotrypsin; Ethylenediamines; Glutamates; Iodoacetates; Leucyl Aminopeptidase; Methotrexate; Peptide Hydrolases; Phenanthrolines; Purines; Pyrimidines; Sarcoma 180; Temperature; Tetrahydrofolate Dehydrogenase; Trypsin | 1966 |